Has Kerry Cleary received payments from drug or device companies?

Yes. Drug and device makers reported $12,464 in general payments to Kerry Cleary across 243 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kerry Cleary did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kerry Cleary come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kerry Cleary

Psychiatry · Birmingham, ALNPI 1255386579

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Tris Pharma Inc at 48.1% of the total. Reporting peaked in 2019 at $5,096 and has fallen 87.6% since, to $630 in 2025. Among psychiatry clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,464in general payments, 2019–2025

Across 243 payments — averaging $51.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tris Pharma Inc$6K
Supernus Pharmaceuticals, Inc.$4K
Corium, LLC$1K
Ironshore Pharmaceuticals Inc.$765
Neos Therapeutics, LP$457
Takeda Pharmaceuticals U.S.A., Inc.$204
plus $461 from 7 others

What the payments were for

Speaking & faculty fees$6,40051%
Travel & lodging$9327%
Food & beverage$5,11141%
Gifts$200%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tris Pharma Inc	46	$5,989
Supernus Pharmaceuticals, Inc.	46	$3,576
Corium, LLC	51	$1,011
Ironshore Pharmaceuticals Inc.	31	$765
Neos Therapeutics, LP	34	$457
Takeda Pharmaceuticals U.S.A., Inc.	11	$204
Adlon Therapeutics L.p.	9	$127
Johnson & Johnson	1	$109
Collegium Pharmaceutical, Inc.	5	$90
Shire North American Group Inc	4	$61
Sunovion Pharmaceuticals Inc.	3	$44
Vertical Pharmaceuticals, LLC	1	$16
Arbor Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Dyanavel XR$5,051
Quillichew ER$2,000
Quillivant XR$1,000
Quillivant$1,000
QELBREE$364
Azstarys$244
Jornay PM 20mg capsules (Bottle of 100)$126
JORNAY PM$125
SPRAVATO$109

How this compares

$12,464 in reported general payments places this provider in the 90th percentile of 400 psychiatry providers in Alabama.

See all psychiatry providers in Alabama →

Other psychiatry in Birmingham

Armand SchachterBirmingham$758K
Stephen HughesBirmingham$683K
Leesha Ellis CoxBirmingham$653K
Godehard OepenBirmingham$516K
Richard SheltonBirmingham$79K
Melissa KarrhBirmingham$51K
Matthew MacalusoBirmingham$49K
Santosh PillaiBirmingham$28K
Jennifer HadleyBirmingham$27K
Praveen JettyBirmingham$10K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →